EVA HINOJOSA: Open Payments
NPI 1760137368 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,801 in 86 payments from 16 companies in 2025. Trend: 2023 $1,378 · 2024 $668 · 2025 $2,801
Food & beverage: $2,587Education: $213
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $469 |
| Galderma Laboratories, L.P. | 13 | $417 |
| GENZYME CORPORATION | 10 | $367 |
| Janssen Biotech, Inc. | 9 | $322 |
| Amgen Inc. | 8 | $264 |
| Novartis Pharmaceuticals Corporation | 4 | $249 |
| Arcutis Biotherapeutics, Inc. | 10 | $198 |
| ABBVIE INC. | 10 | $150 |
| Regeneron Healthcare Solutions, Inc. | 3 | $124 |
| UCB, Inc. | 3 | $85 |
Products named: DUPIXENT, NEMLUVIO, ILUMYA, TREMFYA, OTEZLA, Zoryve, SKYRIZI, Rhapsido.
Industry payments across TX — which companies pay providers there.
